Trials / Completed
CompletedNCT03678558
Oocyte Vitrification Aided With Cytochalasin B
Cytochalasin B for Oocyte Vitrification
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 612 (actual)
- Sponsor
- Ibn Sina Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Using the cytoskeleton Stabilizer the Cytochalasin B would improve the outcome of oocyte vitrification.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cytochalasin B supplemented vitrification medium | Vitrification of human oocyte in medium supplemented with Cytochalasin B |
Timeline
- Start date
- 2018-09-25
- Primary completion
- 2019-08-05
- Completion
- 2019-08-05
- First posted
- 2018-09-19
- Last updated
- 2019-08-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03678558. Inclusion in this directory is not an endorsement.